216
Participants
Start Date
October 10, 2019
Primary Completion Date
October 1, 2025
Study Completion Date
May 1, 2026
I-ACQUIRE - High Dosage
Children in this group will receive 6 hours of I-ACQUIRE therapy daily, 5 days a week for 4 consecutive weeks. Treatment is delivered in the home or homelike setting by a study trained I-ACQUIRE pediatric therapist.
I-ACQUIRE - Moderate Dosage
Children in this group will receive 3 hours of I-ACQUIRE therapy daily, 5 days a week for 4 consecutive weeks. Treatment is delivered in the home or homelike setting by a study trained I-ACQUIRE pediatric therapist.
Usual & Customary Treatment (U&CT)
Children in this group will receive the same U\&CT that they had been receiving prior to the baseline assessment. The type and dosage of treatment(s) will be documented weekly.
Children's Hospital of Philadelphia, Philadelphia
Kennedy Krieger Institute - Fairmount Rehabilitation, Baltimore
Fralin Biomedical Research Institute at Virginia Tech, Roanoke
The Medical University of South Carolina (MUSC), Charleston
Martha Morehouse Medical Plaza, Columbus
Cincinnati Children's Hospital Medical Center, Cincinnati
C.S. Mott Children's Hospital, Ann Arbor
University of Wisconsin School of Medicine and Public Health, Madison
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Washington University School of Medicine, St. Louis Children's Hospital, St Louis
Scottish Rite for Children - Dallas, Dallas
Memorial Hermann Texas Medical Center, Houston
USCD Health La Jolla, La Jolla
Yale New Haven Children's Hospital, New Haven
Boston Children's Hospital, Boston
Ohio State University
OTHER
Nationwide Children's Hospital
OTHER
Stanford University
OTHER
University of Cincinnati
OTHER
Medical University of South Carolina
OTHER
Virginia Polytechnic Institute and State University
OTHER